Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

EXT1

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Exostosin glycosyltransferase 1 (EXT1) is a Golgi‑localized glycosyltransferase encoded by EXT1 gene. This enzyme resides within luminal compartments of Golgi apparatus and associates with Golgi membrane through its N‑terminal region. EXT1 contains conserved catalytic domains responsible for glycan chain polymerization. Its catalytic domain faces the Golgi lumen where nucleotide‑sugar substrates are actively transported into the organelle by specialized transmembrane transporters. EXT1 forms stable functional molecular complexes with additional Golgi‑resident enzymatic partners inside Golgi compartments. This physical complex formation is required to sustain sustained enzymatic activity, and isolated EXT1 monomer exhibits limited catalytic performance without its binding partners. This enzyme is widely expressed across many mammalian cell types, yet its expression magnitude varies among distinct cell populations according to the biosynthetic demand for heparan sulfate modified proteoglycans.

EXT1 participates in stepwise polymerization of heparan sulfate glycosaminoglycan chains onto proteoglycan acceptor backbones. It works in tight coordination with partner enzymes to add successive sugar units during glycan elongation, building long, unbranched glycan chains covalently linked to core proteoglycan protein scaffolds. Loss of functional EXT1 impairs normal heparan sulfate chain assembly and limits the generation of full‑length glycan chains. Other Golgi glycosyltransferases within the same biosynthetic pathway cannot fully compensate for the enzymatic activity contributed by EXT1. Completed heparan sulfate modified proteoglycans are subsequently trafficked through post‑Golgi secretory vesicles toward cell surface or secreted to extracellular compartments. Once delivered outside the Golgi, these proteoglycans participate in diverse molecular recognition events with a broad spectrum of extracellular binding partners. Changes to EXT1 function directly affect the structural composition, chain length and overall abundance of newly synthesized heparan sulfate glycan chains, and such alterations further reshape the molecular interaction capacity of the corresponding proteoglycan molecules.

Fig. 1 Schematic view of EXT1 driven heparan sulfate glycan polymerization for proteoglycan modification, reference illustration for EXT1 related research reagents. (OA Literature)Fig. 1 Schematic of heparan‑sulfate proteoglycan glycan assembly. EXT1‑containing polymerase complex catalyzes step‑wise elongation of disaccharide repeating units onto proteoglycan backbone during glycan biosynthesis.1

EXT1 Protein Function: Core Roles in Heparan Sulfate Glycan Polymerization and Golgi based Glycosylation Processing

The biological functions of EXT1 are focused on heparan sulfate glycan chain polymerization, Golgi compartment glycosylation processing and proteoglycan modification:

  • Glycan Polymerization Catalytic Activity: Conserved catalytic domains support sequential addition of sugar moieties during heparan sulfate chain elongation, working together with partner enzymatic components.
  • Golgi Compartment Processing: Acts within Golgi intracellular compartments to modify nascent proteoglycan acceptor substrates.
  • Proteoglycan Modulation: May shape the structural characteristics of heparan sulfate decorated proteoglycans which are later distributed to cell surface or secreted compartments.
  • Enzymatic Complex Cooperation: Might assemble with additional Golgi resident proteins to establish functional multi-molecular glycosylation complexes.
  • Research Model Relevance: Structural modification of EXT1 could alter glycan polymerization efficiency within laboratory research systems.

EXT1 Membrane Protein Product

Creative Biolabs offers purified EXT1 protein samples via standardized preparation workflows, including full‑length EXT1 constructs and isolated catalytic domain variants. Isolated catalytic domain fragments may not support complete multi‑step glycan polymerization related behaviours, while full‑length constructs may be suited for glycosyltransferase associated glycan assembly related research. All samples receive routine quality screening, and functional relevant observation may only be carried out with full‑length samples under appropriate simulated molecular environments. All sample batches follow unified processing standards to maintain consistent structural features for comparative laboratory analysis across separate test groups.

EXT1 Protein Product

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

EXT1 Stable Cell Line Product

Creative Biolabs provides adjustable EXT1 expression cell models with varied expression levels, applicable to Golgi resident glycosyltransferase structural characteristic observation and intracellular glycan biosynthesis related research. Sample evaluation includes sustained target expression detection and preliminary substrate interaction associated observation, which can support comparative analysis of enzyme relevant behaviours under different expression statuses. These cell systems can be matched with diverse laboratory analysis schemes to observe changes of glycan processing associated efficiency under different target expression abundances.

EXT1 Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

EXT1 Recombinant Antibody Product

Antibody reagents targeting EXT1 are generated via mature protein preparation workflows, compatible with multiple routine laboratory detection methods for subcellular localization profiling and molecular complex identification, to support systematic analysis of EXT1 distribution and glycosylation relevant molecular complexes across diverse laboratory research setups. The antibody series can cooperate with other common laboratory detection reagents to complete multi dimensional observation of target distribution inside tissue samples.

EXT1 Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Catalytic Region Retention Property: Retains native-like glycosyltransferase catalytic domain characteristics, suited for laboratory observation of glycan assembly related molecular behaviours.
  • Target Specific Recognition: May selectively combine with unique structural regions of EXT1, suited for research focused on Golgi glycosyltransferase related mechanisms.
  • Glycosylation Research Adaptability: Designed for routine laboratory analysis of intracellular glycan biosynthesis and proteoglycan modification pathways.
  • Full Customization Support: Tailored EXT1 protein, antibody and cell model development can be arranged to match diversified glycosylation focused research demands.

Custom EXT1 Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for EXT1 research:

  • Custom EXT1 Protein Production: Tailored mutant and tagged EXT1 constructs for glycan polymerization associated molecular analysis.
  • Custom Antibody Development: Generation of EXT1 antibodies for subcellular distribution observation and enzymatic complex detection.
  • Stable Cell Line Engineering: Construction of customized cell systems with adjustable EXT1 expression levels.
  • Functional Assay Development: Custom design of detection workflows for glycosyltransferase associated molecular observation.

Frequently Asked Questions (FAQ)

  1. What is the primary function of EXT1?

    EXT1 may function as a Golgi resident glycosyltransferase and participate in heparan sulfate glycan chain polymerization for proteoglycan modification.

  2. Why is EXT1 a significant research target?

    EXT1 functional status may influence heparan sulfate biosynthesis and proteoglycan glycan profiles, serving as a major regulatory mediator of intracellular glycosylation related biological processes.

  3. Are Creative Biolabs' EXT1 products suitable for clinical use?

    No, all EXT1 related products and services are strictly for research use only, not intended for clinical related operations. All material designs and functional tests are only optimized for basic laboratory research scenarios, without matching clinical application standards.

  4. What types of EXT1 products does Creative Biolabs offer?

    Offerings include full‑length EXT1 protein, target specific recombinant antibodies and adjustable expression cell research models, supporting glycosaminoglycan biosynthesis and intracellular glycosylation research.

  5. How to observe the functional characteristics of EXT1 samples in laboratory research?

    Laboratory observation schemes may include glycan assembly associated tests to analyse enzyme relevant behaviours under simulated molecular environments.

Reference
  1. Mashima, Ryuichi, Torayuki Okuyama, and Mari Ohira. "Physiology and pathophysiology of heparan sulfate in animal models: its biosynthesis and degradation." International journal of molecular sciences 23.4 (2022): 1963. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms23041963
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
;